How pharma uses fear of fentanyl to extract profits from naloxone; Biden's budget boosts funds for future pandemics

Taking stock of the drug industry, from the lab to the medicine chest

March 28, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Mike Reddy for STAT How the drug industry uses fear of fentanyl to extract more profit from naloxone Drugmakers are aggressively marketing high-cost and high-dose naloxone products that divert resources away from cheaper forms of the life-saving medication. By Lev Facher Opinion: Biden's budget boosts funds for future pandemics, but cuts them for current ones Under the proposed Biden budget, U.S. funding for global tuberculosis, malaria, and HIV/AIDS all get scaled back. By Colin Puzo Smith STAT+ | With new study data, Intra-Cellular could expand use of approved mood-disorder treatment The results bolster confidence the drug could also prove effective for people with major depressive disorder and so-called mixed features. By Adam Feuerstein Mariam Zuhaib/AP Republicans press Becerra on gender-affirming care, reproductive rights Republicans hammered Biden's health secretary Tuesday, previewing a line of political attacks likely to dominate the 2024 elections. By Sarah Owermohle STAT+ | Viking Therapeutics releases early but promising weight loss data on new GLP-1 drug The company said its experimental medicine led patients to lose as much as 6% more body weight than those on placebo in just 28 days. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser